Nucleic Acids, Nucleotides, and Nucleosides

DBCAT000256Pharmacologic class

Complex compounds of high molecular weight occurring in living cells. These are basically of two types, ribonucleic (RNA) and deoxyribonucleic (DNA) acids, both of which consist of nucleotides (nucleoside phosphates linked together by phosphate bridges). A DrugBank category of 352 drugs. 73 of them are approved.

Also known as: Nucleoside analogues · Nucleoside analogue
Drugs: (R)-methylmalonyl-CoA
(Rp)-cAMPS
1-(5-phospho-D-ribosyl)-ATP
2-Fluoroadenosine
2'-C-methylcytidine
2'-cytidylic acid
2'-Deoxy-thymidine-beta-L-rhamnose
2'-Deoxycytidine 5'-triphosphate
2'-deoxythioguanosine
2'-Deoxyuridine
2'-fluoro-5-ethylarabinosyluracil
2',3'-Dideoxyadenosine triphosphate
3-Acetylpyridine Adenine Dinucleotide
3-Deazaadenosine
3-Deazacytidine
3-Hydroxybutyryl-Coenzyme A
3'-Uridinemonophosphate
4-hydroxybenzoyl-CoA
5-fluoro-2'-deoxycytidine
5-fluoro-2'-deoxyuridine-5'-monophosphate
5-fluorouridine
5-iodotubercidin
5-methylcytidine 5'-monophosphate
5-Methyluridine triphosphate
5,6-dihydro-5-azacytidine
and 327 more with a free account

What you can answer from here — as of May 14, 2018

352DrugsEach linked to its full drug card

810Drug targetsEvery drug–target pair in the class, with bond type

6,257Marketed productsAcross the regions we cover, with dosage forms and routes

24Routes of administrationHow the drugs in this class are given

Which targets do Nucleic Acids, Nucleotides, and Nucleosides share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account